Thane Wettig - 07 Jun 2023 Form 4/A - Amendment Insider Report for FIBROGEN INC (FGEN)

Role: Chief Commercial Officer
Signature: /s/ Cecelia Monoarfa-Taime, Attorney-in-fact
Issuer symbol: FGEN
Transactions as of: 07 Jun 2023
Net transactions value: -$29,951
Form type: 4/A - Amendment
Filing time: 22 Jun 2023, 18:32:29 UTC
Date Of Original Report: 09 Jun 2023
Previous filing: 24 Mar 2023
Next filing: 26 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FGEN	Common Stock	Sale	$8,041	-472	-0.43%	$17.04^*	110,338	07 Jun 2023	Direct	F1, F2
transaction	FGEN	Common Stock	Sale	$21,910	-1,286	-1.2%	$17.04^*	109,052	07 Jun 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
F2	Includes 2,500 shares acquired on May 15, 2023 through the Issuer's Employee Stock Purchase Plan.

Remarks:

This amendment to Form 4 is being filed solely to correct an inadvertent math error contained in the end of period holdings in Box 5 of the Form 4 filed on June 9, 2023.